Doxycycline monohydrate (CAS 17086-28-1)
See product citations (9)
QUICK LINKS
Doxycycline monohydrate is a broad-spectrum compound extensively studied in the field of biochemistry and molecular biology. In research applications, it is often used as a tool to explore the inhibition of protein synthesis in prokaryotic cells, which can provide insights into the mechanisms of ribosomal function. Additionally, the compound is applied in the study of gene expression, where it acts as a regulator in inducible gene expression systems in both bacterial and mammalian cells. This ability to control gene expression makes Doxycycline monohydrate valuable for investigating gene function and the molecular pathways within cells. It is also used in the study of metalloproteinase (MMP) inhibitors, as it is known to affect the expression and activity of these enzymes that are involved in the degradation of extracellular matrix components. Research involving Doxycycline monohydrate also encompasses its role in the elucidation of microbial resistance mechanisms.
Doxycycline monohydrate (CAS 17086-28-1) References
- Susceptibility of bacteria from feline and canine urinary tract infections to doxycycline and tetracycline concentrations attained in urine four hours after oral dosage. | Wilson, BJ., et al. 2006. Aust Vet J. 84: 8-11. PMID: 16498827
- Update on rosacea and anti-inflammatory-dose doxycycline. | Berman, B., et al. 2007. Drugs Today (Barc). 43: 27-34. PMID: 17315050
- Lupus Miliaris Disseminatus Faciei With Isolated Axillary Involvement. | Kim, WB. and Mistry, N. 2016. J Cutan Med Surg. 20: 153-4. PMID: 26471742
- Subantimicrobial-dose doxycycline monohydrate in dermatology. | Wollina, U. 2015. Wien Med Wochenschr. 165: 499-503. PMID: 26564206
- Enteric Coating Reduces Upper Gastrointestinal Adverse Reactions to Doxycycline. | Järvinen, A., et al. 1995. Clin Drug Investig. 10: 323-7. PMID: 27519332
- Application of Metal-Organic Framework Nano-MIL-100(Fe) for Sustainable Release of Doxycycline and Tetracycline. | Taherzade, SD., et al. 2017. Nanomaterials (Basel). 7: PMID: 28783087
- Morbihan disease: successful treatment with slow-releasing doxycycline monohydrate. | Chaidemenos, G., et al. 2018. J Eur Acad Dermatol Venereol. 32: e68-e69. PMID: 28833773
- Electrospun nanofibers comprising of silk fibroin/gelatin for drug delivery applications: Thyme essential oil and doxycycline monohydrate release study. | Dadras Chomachayi, M., et al. 2018. J Biomed Mater Res A. 106: 1092-1103. PMID: 29210169
- Doxycycline release and antibacterial activity from PMMA/PEO electrospun fiber mats. | Carvalho, LD., et al. 2019. J Appl Oral Sci. 27: e20180663. PMID: 31596368
- On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified? | Azad, MA., et al. 2019. Pharm Res. 36: 167. PMID: 31650274
- Doxycycline-Associated Dual Cutaneous Adverse Reaction to the Drug (CARD): Case Report of Concurrent Photosensitivity and Morbilliform Exanthem to Doxycycline. | Jacob, JS. and Cohen, PR. 2020. Cureus. 12: e11546. PMID: 33365215
- Clinical and laboratory assessment of the role of the conditionally pathogenic sexually transmitted flora in the formation of the pathological state of the cervix and cervical canal in women of reproductive age. | Abdrakhmanov, AR. and Abdrakhmanov, RM. 2022. Minerva Obstet Gynecol. 74: 60-67. PMID: 35196853
- Doxycycline-Associated Hyperpigmentation: A Case Report and Literature Review. | Afrin, A. and Cohen, PR. 2022. Cureus. 14: e23754. PMID: 35509754
- Antibiotic prescribing trends in primary care 2014-2022. | McCloskey, AP., et al. 2023. Res Social Adm Pharm.. PMID: 37183105
- Bioavailability of doxycycline monohydrate. A comparison with equivalent doses of doxycycline hydrochloride. | Malmborg, AS. 1984. Chemotherapy. 30: 76-80. PMID: 6697815
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Doxycycline monohydrate, 5 g | sc-263109 | 5 g | $73.00 | |||
Doxycycline monohydrate, 25 g | sc-263109A | 25 g | $200.00 |